One Nucleus Signs Agreement with Bionow to Expand Access to One Nucleus Preferred Suppliers
News Jan 04, 2011
One Nucleus is delighted to announce that an agreement has been signed with Bionow for their Premium Members to have access to the One Nucleus Preferred Suppliers through the One Nucleus Purchasing Consortium Scheme. This agreement took effect on 1 January 2011.
The One Nucleus Purchasing Consortium has an annual spend of over £6 million with its 8 Preferred Suppliers and over 70 One Nucleus Gold Members. The consortium aims to utilise the buying volume of member companies to negotiate and promote Preferred Supply Agreements. The aim is not only to provide bottom line cost savings for members but to also provide added value services that would not normally be available to One Nucleus member companies on an individual basis.
Richard Dickinson, Director of Specialist Services at One Nucleus said “One Nucleus and Bionow are working together in partnership to leverage the combined buying power in a way that benefits all our member companies”.
Geoff Davison, CEO of Bionow said ”I am delighted that Bionow is able to leverage this significant saving power for our member companies. By accessing this scheme our members will be able to make the savings that will allow them to compete more effectively, significantly strengthening the UK offer in life sciences.”
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
Innate Reaction of Hematopoietic Stem Cells to Severe InfectionsNews
Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide, without signals from growth factors.READ MORE
Comments | 0 ADD COMMENT
Like what you just read? You can find similar content on the communities below.Biopharma Cancer Research Cell Science Drug Discovery Genomics Research Informatics & Automation Microfluidics
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for FreeLOGIN SUBSCRIBE FOR FREE